Physician profile
Keith Swartz
NPI 1720039555
$5,106.08
in general payments reported to CMS, 2019-2025
19 companies · $509 in 2025
The $509 reported for 2025 was less than what a typical Sleep Medicine (Otolaryngology) provider received nationally (typical 2025 total: $509).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $233 · 2020: $2,263 · 2021: $321 · 2022: $952 · 2023: $390 · 2024: $438 · 2025: $509.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,337.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,337.01 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Inspire Medical Systems, INC. | $4,398.76 | 2019-2025 | Inspire |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $134.63 | 2024 | Lifevest |
| Itamar Medical INC | $120.00 | 2025 | Watchpatone |
| Zoll Respicardia, INC. | $109.95 | 2021 | |
| Optinose US, INC. | $55.07 | 2019-2020 | |
| Aerin Medical INC. | $47.53 | 2020-2024 | |
| Jazz Pharmaceuticals INC. | $32.10 | 2020 | |
| Stryker Corporation | $31.56 | 2020 | |
| Glaxosmithkline, LLC. | $27.82 | 2019-2024 | Nucala |
| Lilly USA, LLC | $26.95 | 2025 | Zepbound |
| Ethicon US, LLC | $19.38 | 2019 | |
| Idorsia Pharmaceuticals US INC | $19.00 | 2023 | Quviviq |
| Kaleo, INC. | $16.61 | 2023 | Auvi-Q |
| Resmed Corp | $14.41 | 2019 | |
| Biohaven Pharmaceutical Holding Company LTD. | $14.00 | 2022 |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Genzyme Corporation | $13.33 | 2020 | |
| Cook Medical LLC | $12.81 | 2020 | |
| Eisai INC. | $12.17 | 2021 |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Keith Swartz listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.